Legacy Giving

Imagine: a future when men no longer suffer or die from the most common cancer in Canadian men - prostate cancer.

By leaving a gift in your will, you can continue to help shape a brighter tomorrow for our sons and their loved ones after you're gone.

Your legacy of giving will carry on as future generations of Canadian men lead fuller, healthier, and happier lives than ever before.

What will your legacy be?

Benefits of leaving a gift in your will

Gifts in a will are, by far, the most popular type of legacy gift. Also known as bequests, gifts in a will are popular for the following reasons:
  • You will help support Canadian men living with prostate cancer without touching the assets and funds you need now.
  • You can change your mind at any time and amend or revoke the gift.
  • It reduces the taxes payable on your estate as your estate will receive a charitable tax receipt for the gift.


How do I leave a gift in my will?

Creating your legacy gift is as easy as 1,2,3!
  1. Make an appoitment with your lawyer.
  2. Create a new will or amend an existing will to reflect your wishes.
  3. Contact Prostate Cancer Canada so that we may thank you for your gift.

For any questions or concerns, please contact...

Maria Glidden
Coordinator, Donor Relations and Stewardship
maria.glidden@prostatecancer.ca
(416) 441-2131 ext. 277



Plaid for Dad


Subscribe to our free monthly e-newsletter!

* indicates required

 





 
PCC Spotlight
Honouring dad this Father’s Day the Canadian way: In plaid

TORONTO, ON – (May 8, 2018) – Plaid replaces business-casual on Friday, June 15 as hundreds of thousands of Canadians don the iconic Canadian attire all to honour dad and end prostate cancer.
More

The Finger – A tried and true method to save lives

TORONTO, CANADA (May 8, 2018) – Every day, more and more methods to detect prostate cancer are being explored, but the tried and true methods of a digital rectal examination (DRE) – where a healthcare professional inserts a gloved finger into the rectum to check for abnormalities, paired with a blood test known as the prostate-specific antigen (PSA) test – which you can get through your family doctor, are still the long-standing proven ways to save a life.
More

Landmark study links tumour evolution to prostate cancer severity

Toronto (April 19, 2018) – Findings from Canadian Prostate Cancer Genome Network (CPC-GENE) researchers and their collaborators, published today in Cell, show that the aggressiveness of an individual prostate cancer can be accurately assessed by looking at how that tumour has evolved.
More


Click here for news archive